Literature DB >> 25677358

Guidelines for severe uncontrolled asthma.

Carolina Cisneros Serrano1, Carlos Melero Moreno2, Carlos Almonacid Sánchez3, Miguel Perpiñá Tordera4, César Picado Valles5, Eva Martínez Moragón6, Luis Pérez de Llano7, José Gregorio Soto Campos8, Isabel Urrutia Landa9, Gloria García Hernández10.   

Abstract

Since the publication, 9 years ago, of the latest SEPAR (Spanish Society of Pulmonology and Thoracic Surgery) Guidelines on Difficult-to-Control Asthma (DCA), much progress has been made in the understanding of asthmatic disease. These new data need to be reviewed, analyzed and incorporated into the guidelines according to their level of evidence and recommendation. Recently, consensus documents and clinical practice guidelines (CPG) addressing this issue have been published. In these guidelines, specific mention will be made of what the previous DCA guidelines defined as "true difficult-to-control asthma". This is asthma that remains uncontrolled after diagnosis and a systematic evaluation to rule out factors unrelated to the disease itself that lead to poor control ("false difficult-to-control asthma"), and despite an appropriate treatment strategy (Spanish Guidelines for the Management of Asthma [GEMA] steps 5 and 6): severe uncontrolled asthma. In this respect, the guidelines propose a revised definition, an attempt to classify the various manifestations of this type of asthma, a proposal for a stepwise diagnostic procedure, and phenotype-targeted treatment. A specific section has also been included on DCA in childhood, aimed at assisting healthcare professionals to improve the care of these patients.
Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Asma grave; Asma no controlada; Asthma phenotype; Asthma treatment; Fenotipado del asma; Severe asthma; Tratamiento del asma; Uncontrolled asthma

Mesh:

Substances:

Year:  2015        PMID: 25677358     DOI: 10.1016/j.arbres.2014.12.007

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  6 in total

1.  Economic burden of severe asthma treatment: A real-life study.

Authors:  Jesús López-Tiro; Angelica Contreras-Contreras; M Eunice Rodríguez-Arellano; Paula Costa-Urrutia
Journal:  World Allergy Organ J       Date:  2022-07-04       Impact factor: 5.516

Review 2.  Integration of in vitro allergy test results and ratio analysis for the diagnosis and treatment of allergic patients (INTEGRA).

Authors:  Mariona Pascal; Carmen Moreno; Ignacio Dávila; Ana I Tabar; Joan Bartra; Moisés Labrador; Olga Luengo
Journal:  Clin Transl Allergy       Date:  2021-08       Impact factor: 5.657

3.  Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma.

Authors:  Carolina Cisneros; Rocío Magdalena Díaz-Campos; Núria Marina; Carlos Melero; Alicia Padilla; Silvia Pascual; Celia Pinedo; Andrea Trisán
Journal:  J Asthma Allergy       Date:  2017-05-09

Review 4.  dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies.

Authors:  Óscar Palomares; Silvia Sánchez-Ramón; Ignacio Dávila; Luis Prieto; Luis Pérez de Llano; Marta Lleonart; Christian Domingo; Antonio Nieto
Journal:  Int J Mol Sci       Date:  2017-06-21       Impact factor: 5.923

5.  Is asthma in the elderly different? Functional and clinical characteristics of asthma in individuals aged 65 years and older.

Authors:  Elena Curto; Astrid Crespo-Lessmann; María Victoria González-Gutiérrez; Santiago Bardagí; Concepción Cañete; Concha Pellicer; Teresa Bazús; María Del Carmen Vennera; Carlos Martínez; Vicente Plaza
Journal:  Asthma Res Pract       Date:  2019-03-19

6.  Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study.

Authors:  Luis Manuel Entrenas Costa; Francisco Casas-Maldonado; José Gregorio Soto Campos; Alicia Padilla-Galo; Alberto Levy; Francisco Javier Álvarez Gutiérrez; Ana P Gómez-Bastero Fernández; Concepción Morales-García; Rocío Gallego Domínguez; Gustavo Villegas Sánchez; Luis Mateos Caballero; Antonio Pereira-Vega; Cayo García Polo; Gerardo Pérez Chica; Juan José Martín Villasclaras
Journal:  Pharmacoecon Open       Date:  2019-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.